CBD/THC/terpene consistent formulas

Abstract

A method to produce a consistent product batch of cannabis and hemp plant active ingredients by isolating and separating the cannabis and hemp plant ingredients in prior processes and recombining the isolated ingredients in specify amounts for the final product. Encapsulating active ingredients together at different body internal release times to even out the active ingredient effects on the body over a time period to reduce highs and lows.

Claims

1. A method of treating Alzheimer's disease in a human in need thereof consisting essentially of administering to said human in need thereof an extended release capsule consisting essentially of therapeutically effective amounts of isolated THC, isolated CBD, valerian root, gaba, caffeine, and melatonin to effectively treat the Alzheimer's in said human in need thereof.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) FIG. 1 shows a chart of CBD ingredients.

(2) FIG. 2 shows a chart of a list of actions associated with Terpenes.

(3) FIG. 3 shows a chart of medical benefits of Terpenes.

(4) FIG. 4 shows Terpene health benefits.

(5) FIG. 5 shows a cutaway diagram of encapsulated active ingredient.

DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION

(6) An example below for a formula, for end product consistency, add 1 milligram of each of the following previously isolated, separated components/compounds/ingredients in a prior separation/extraction process, to provide for the first time a consistent final product formula on an ongoing basis, without deviation and with complete consistency, including adding other drugs, medicines and or nutraceuticals of any kind. The following is only an example to show the invention is critical and cannot be done without the invention process, if a formula needed to be 1 milligram of each: cannabigerol (CBG), cannabichromene (CBC), cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol (CBN) and cannabinodiol (CBDL), cannabicyclol (CBL), cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), cannabigerol monomethyl ether (CBGM), cannabinerolic acid, cannabidiolic acid (CBDA), cannabinol propyl variant (CBNV), cannabitriol (CBO), tetrahydrocannabinolic acid (THCA), and tetrahydrocannabivarinic acid (THCVA) and terpenes such as: aromadendrene, bergamottin, bergamotol, bisabolene, borneol, 4-3-carene, caryophyllene, cineole/eucalyptol, p-cymene, dihydrojasmone, elemene, farnesene, fenchol, geranylacetate, guaiol, humulene, isopulegol, limonene, linalool, menthone, menthol, menthofuran, myrcene, nerylacetate, neomenthylacetate, ocimene, perillylalcohol, phellandrene, pinene, pulegone, sabinene, terpinene, terpineol, terpineol-4-ol, terpinolene, and derivatives, isomers, enantiomers.

(7) Another embodiment of the present invention provides a time release/extended release composition comprising certain ingredients that can be provided that are from Evonics and Colorcon among other companies, ingredients that can provide coating materials, including other ingredients that can be used in itself or part of such as dextrin's, starch and chitosan.

(8) Thereof one or more nutra and/or pharma excipients that are for multi hour release of active materials instead of all at once. Manufacturing can be done in a coating pan, fluid beds, among other type of spray drying techniques to provide a controlled release pattern that can be layered with multiple coatings and multiple coating ingredients, depending on the release of what is desired, to protect against moisture, to help in odor and taste reduction, and to making oil into water soluble products.

(9) Furthermore, specific coating materials can be used so that certain active ingredient(s) will only dissolve/enter into the blood stream in specific areas of the body such as stomach, large intestine, duodenum and ileum. With this technique with certain minerals, vitamins, herbs and or drugs, the amount of actives used can be much less than a standard dose due to releasing, specifically including time release over time, of the active ingredient(s). There are many formulas that can be done by this invention, and below are some examples, but are not limited to the examples, as there are limitless combinations that now can be done based on this invention.

Encapsulation Example 1

(10) 100 mg caffeine, 100 mg taurine, 20 mg niacin, 50 mg potassium, 5 mg magnesium, 1 mg CBD, 1 mg THC, 1 mg THCA, 1 mg CBG and 30 mg of calcium every hour over a period of 7 hours.

Encapsulation Example 2

(11) 2 mg melatonin, 30 mg valerian root, 35 mg 1-tryptophan, 15 mg gaba, 1 mg CBD, 1 mg THC, 1 mg THCA, 1 mg CBG.

Encapsulation Example 3

(12) mg of CBD, either isolate, full spectrum or broad spectrum, 1 mg CBD, 1 mg THC, 1 mg THCA, 1 mg CBG and or any amounts of terpenes or any single or any combination thereof, release every hour on the hour for a period of 8 hours or any amount of hours desired.

(13) With this invention there are unlimited amounts of new medicines that are manmade/synthetic or by nature that have enormous applications to the body and market. Having ingredients release overtime is the most efficient way of obtaining the highest bioavailability possible to any human or animal.

(14) Furthermore the ingredients/compounds can be microencapsulated for specific time release, targeted release, making water soluble oil to odor and taste masking that can be crucial for specific formulas.